Frederico Silva Castelo Branco

<i>In vitro</i> antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19

Carolina Q. Sacramento, Natalia Fintelman‐Rodrigues, Jairo R. Temerozo et al. · Journal of Antimicrobial Chemotherapy · 2021 · 102 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

New hydrazides derivatives of isoniazid against Mycobacterium tuberculosis: Higher potency and lower hepatocytotoxicity

Frederico Silva Castelo Branco, E.C.D. Lima, Jorge L. O. Domingos et al. · European Journal of Medicinal Chemistry · 2018 · 41 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

The <i>in vitro</i> antiviral activity of the anti-hepatitis C virus (HCV) drugs daclatasvir and sofosbuvir against SARS-CoV-2

Carolina Q. Sacramento, Natalia Fintelman‐Rodrigues, Jairo R. Temerozo et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 37 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Phenylhydrazides as inhibitors of Leishmania amazonensis arginase and antileishmanial activity

E.C.D. Lima, Frederico Silva Castelo Branco, Claudia do Carmo Maquiaveli et al. · Bioorganic & Medicinal Chemistry · 2019 · 20 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Drug screening and development cascade for Chagas disease: an update of in vitro and in vivo experimental models.

Maria de Nazaré Correia Soeiro, Policarpo Ademar Sales, Valéria Rêgo Alves Pereira et al. · PubMed · 2024 · 12 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17